Jeffrey M Dener

Title: Innovations of Jeffrey M Dener

Introduction

Jeffrey M Dener is a notable inventor based in King of Prussia, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antithrombotic agents. With a total of two patents to his name, Dener's work focuses on innovative solutions to complex medical challenges.

Latest Patents

Dener's latest patents include "Antithrombotic peptides and pseudopeptides" and "Synthesis of optically active lactones from L-aspartic acid." The first patent relates to novel peptide and pseudopeptide derivatives and analogs of aspartic acid, which serve as inhibitors of platelet aggregation and thrombus formation in mammalian blood. This invention also encompasses pharmaceutical compositions that include these compounds and their applications in inhibiting thrombus formation and platelet aggregation in mammals. The second patent describes optically active lactones, which are prepared from L-aspartic acid and can be converted to (+)-pilocarpine and its analogues through various chemical processes.

Career Highlights

Throughout his career, Jeffrey M Dener has worked with prominent organizations, including Rhone-Poulenc Rorer Pharmaceuticals Inc. and the University of California. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Dener has collaborated with notable colleagues such as Scott I Klein and Bruce F Molino, further enhancing his contributions to the field of innovation in pharmaceuticals.

Conclusion

Jeffrey M Dener's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents reflect a commitment to advancing medical science and improving patient outcomes.